BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2878631)

  • 21. A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.
    Montgomery CJ; Steward DJ
    Can J Anaesth; 1988 Jan; 35(1):36-40. PubMed ID: 2894902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edrophonium priming for antagonism of atracurium neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Can J Anaesth; 1990 Mar; 37(2):197-201. PubMed ID: 2311149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vecuronium in the myasthenic patient.
    Hunter JM; Bell CF; Florence AM; Jones RS; Utting JE
    Anaesthesia; 1985 Sep; 40(9):848-53. PubMed ID: 2864878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atracurium, vecuronium and pancuronium. Results of a polygraphic study].
    Bifarini G; Tesoro S; Favetta P; Cirulli P; Paoletti F; Ciammitti C
    Minerva Anestesiol; 1989 Nov; 55(11):457-62. PubMed ID: 2576684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
    Naguib M
    Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vecuronium bromide in anaesthesia for laparoscopic sterilization.
    Caldwell JE; Braidwood JM; Simpson DS
    Br J Anaesth; 1985 Aug; 57(8):765-9. PubMed ID: 2861837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neostigmine and 4-aminopyridine antagonism of lincomycin-pancuronium neuromuscular blockade in man.
    Booij LH; Miller RD; Crul JF
    Anesth Analg; 1978; 57(3):316-21. PubMed ID: 566050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atracurium recovery: prediction of safe reversal times with edrophonium.
    Cashman JN; Jones RM; Adams AP
    Anaesthesia; 1989 Oct; 44(10):805-7. PubMed ID: 2589604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting train-of-four fade.
    Pearce AC; Casson WR; Jones RM
    Br J Anaesth; 1985 Jun; 57(6):602-6. PubMed ID: 2860913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative neuromuscular function in pediatric day-care patients.
    Baxter MR; Bevan JC; Samuel J; Donati F; Bevan DR
    Anesth Analg; 1991 Apr; 72(4):504-8. PubMed ID: 1672489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of doxapram on the rate of recovery from atracurium and vecuronium neuromuscular block.
    Cooper R; McCarthy G; Mirakhur RK; Maddineni VR
    Br J Anaesth; 1992 May; 68(5):527-8. PubMed ID: 1353680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atracurium, vecuronium, and pancuronium do not alter the minimum alveolar concentration of halothane in humans.
    Fahey MR; Sessler DI; Cannon JE; Brady K; Stoen R; Miller RD
    Anesthesiology; 1989 Jul; 71(1):53-6. PubMed ID: 2568768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
    Debaene B; Meistelman C; d'Hollander A
    Anesthesiology; 1989 Dec; 71(6):840-4. PubMed ID: 2574016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.